Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes
Primary Purpose
Breast Neoplasms
Status
Suspended
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Cryo-assisted core needle biopsy
FNA
Sponsored by

About this trial
This is an interventional diagnostic trial for Breast Neoplasms focused on measuring breast neoplasms, Ultrasonography, Interventional, Biopsy, Large-Core Needle, Biopsy, Fine-Needle
Eligibility Criteria
Inclusion Criteria:
- Histologically confirmed invasive breast cancer.
- With axillary lymph node with thickened cortex.
- Planned for sentinel lymph node biopsy or axillary clearance.
Exclusion Criteria:
- Nodes ultrasonographically normal.
- Nodes with hilar displacement .
- Palpable matted nodes.
Sites / Locations
- Peking University People's Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Cryo-assisted core needle biopsy
Fine needle aspiration alone
Arm Description
Eligible patients undergo lymph node biopsy with FNA and crpo-assisted stick freeze device sequentially.
Patients undergo lymph node biopsy with FNA alone.
Outcomes
Primary Outcome Measures
Sensitivity of biopsy
True positive rate measures the proportion of positives that are correctly identified by Core needle or FNA
Secondary Outcome Measures
Specificity
The true negative rate measures the proportion of negatives that are correctly identified.
Sample adequency
The specimen amount or quality for diagnosis is adequate or not evaluated by pathologists
Adverse effect of surgery
Hematoma, bleeding need , suture exposure and extrusion.
Full Information
NCT ID
NCT03130946
First Posted
April 23, 2017
Last Updated
October 14, 2022
Sponsor
Peking University People's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03130946
Brief Title
Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes
Official Title
Comparison of the Accuracy and Safety of Biopsy in Suspicious Axillary Lymph Nodes With a Crypo-assisted Stick Freeze Biopsy Device or Fine Needle Aspiration
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Suspended
Why Stopped
Slow recruiting rate.
Study Start Date
May 1, 2017 (Actual)
Primary Completion Date
December 1, 2022 (Anticipated)
Study Completion Date
December 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Peking University People's Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
Axillary lymph node status is a vital prognostic factor in breast cancer patients and provides crucial information for making treatment decisions. Ultrasound test with subsequent fine needle aspiration (FNA) biopsy in nodes with suspicious features remains the standard of axillary lymph node workup. Insufficient sampling and limited diagnostic accuracy of cytological test compromise the outcome the preoperative lymph node staging strategy especially in patients with intermediate suspicious nodes. This prospective study is to compare the performance of a crpo-assisted core biopsy with FNA.
Detailed Description
This prospective study was planned to evaluate the superiority of a core needle biopsy device with a special cryo-assisted rotational design (Cassi II, USA) compared with FNA for biopsy of intermediately suspicious lymph nodes. Eligible patients would be randomized to one of two arms by 1:2 : Core with FNA or FNA alone. The diagnostic accuracy and adverse outcome of core and FNA would be compared.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Neoplasms
Keywords
breast neoplasms, Ultrasonography, Interventional, Biopsy, Large-Core Needle, Biopsy, Fine-Needle
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Two arm, prospective, open label study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
135 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Cryo-assisted core needle biopsy
Arm Type
Experimental
Arm Description
Eligible patients undergo lymph node biopsy with FNA and crpo-assisted stick freeze device sequentially.
Arm Title
Fine needle aspiration alone
Arm Type
Active Comparator
Arm Description
Patients undergo lymph node biopsy with FNA alone.
Intervention Type
Device
Intervention Name(s)
Cryo-assisted core needle biopsy
Intervention Description
Rotational core needle biopsy would be done under local anesthesia. A small incision would be made in the axilla and core needle biopsy be performed using a special cryo-assisted stick freeze device (Cassi II, Scion Medical Technologies, USA). The cytological and histological specimens would be sent for diagnosis.
Intervention Type
Device
Intervention Name(s)
FNA
Intervention Description
FNA would be performed using a 10ml syringe with a 24 gauge needle without anesthesia.
Primary Outcome Measure Information:
Title
Sensitivity of biopsy
Description
True positive rate measures the proportion of positives that are correctly identified by Core needle or FNA
Time Frame
Immediate after pathological lymph node stage is available
Secondary Outcome Measure Information:
Title
Specificity
Description
The true negative rate measures the proportion of negatives that are correctly identified.
Time Frame
Immediate after pathological lymph node stage is available.
Title
Sample adequency
Description
The specimen amount or quality for diagnosis is adequate or not evaluated by pathologists
Time Frame
Immediate after biopsy specimen is evaluated by pathologists.
Title
Adverse effect of surgery
Description
Hematoma, bleeding need , suture exposure and extrusion.
Time Frame
4 weeks after surgery.
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Histologically confirmed invasive breast cancer.
With axillary lymph node with thickened cortex.
Planned for sentinel lymph node biopsy or axillary clearance.
Exclusion Criteria:
Nodes ultrasonographically normal.
Nodes with hilar displacement .
Palpable matted nodes.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shu Wang, MD
Organizational Affiliation
Peking University People's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Peking University People's Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
10044
Country
China
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes
We'll reach out to this number within 24 hrs